Search - tctmd.com

Displaying 81 - 99 of 99

Sort: Relevancy | Date

Presentation TCT 2012

P2Y12 Inhibitors: Specific Agents for Specific Patient Cohorts? (STEMI, Diabetes, CKD, Prior Stroke, Etc.)

Presenter: Dirk Sibbing

October 22, 2012

Presentation TCT 2012

P2Y12 Inhibitors: Could Platelet Reactivity to Balance Between Bleeding and Ischemic Events

Presenter: Laurent Bonello

October 22, 2012

News Daily News

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Jason Kahn

July 17, 2012

News Daily News

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

July 10, 2012

News Daily News

Switching to Non-CYP3A4-Metabolized Statins May Reduce High Platelet Reactivity

April 25, 2012

News Daily News

Universal Definition of MI Shifts Advantage Toward Cangrelor in PCI

Caitlin E. Cox

March 20, 2012

News Daily News

PLATO Analysis: PPIs Problematic with Both Ticagrelor, Clopidogrel

Caitlin E. Cox

March 06, 2012

News Industry News

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT

November 08, 2011

News Daily News

Updated PCI, CABG Guidelines Highlight Interventional-Surgical Collaboration

November 06, 2011

News Daily News

Clopidogrel Reactions Treatable Without Stopping Antiplatelet Therapy

September 21, 2011

News Daily News

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

L.A. McKeown

September 20, 2011

News Daily News

Study Applies Standardized Bleeding Definition to Disparate Antiplatelet Trials

June 15, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

News Daily News

GRAVITAS Published: No Benefit from High-Dose Clopidogrel in Poor Responders

L.A. McKeown

March 15, 2011

News Industry News

2011 Surgical Guidelines Recommend Point-of-Care Platelet Reactivity Testing Prior to Surgery

March 08, 2011

News Daily News

PLATO CABG Cohort: Ticagrelor Cuts Total and CV Mortality in Half

L.A. McKeown

January 03, 2011

CME

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Partner Content

CME Landing Page

November 22, 2016

Partner Content

Registration: A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

November 21, 2016

Advertisement

P2Y12 Inhibitors: Specific Agents for Specific Patient Cohorts? (STEMI, Diabetes, CKD, Prior Stroke, Etc.)

P2Y12 Inhibitors: Could Platelet Reactivity to Balance Between Bleeding and Ischemic Events

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

Switching to Non-CYP3A4-Metabolized Statins May Reduce High Platelet Reactivity

Universal Definition of MI Shifts Advantage Toward Cangrelor in PCI

PLATO Analysis: PPIs Problematic with Both Ticagrelor, Clopidogrel

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT

Updated PCI, CABG Guidelines Highlight Interventional-Surgical Collaboration

Clopidogrel Reactions Treatable Without Stopping Antiplatelet Therapy

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

Study Applies Standardized Bleeding Definition to Disparate Antiplatelet Trials

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

GRAVITAS Published: No Benefit from High-Dose Clopidogrel in Poor Responders

2011 Surgical Guidelines Recommend Point-of-Care Platelet Reactivity Testing Prior to Surgery

PLATO CABG Cohort: Ticagrelor Cuts Total and CV Mortality in Half

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

CME Landing Page

Registration: A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content